Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
JiangSu WuZhong Pharmaceutical Development Co., Ltd., commonly referred to as WuZhong Pharma, is a prominent player in the pharmaceutical industry, headquartered in Jiangsu, China. Established in 2001, the company has made significant strides in drug development, focusing on innovative solutions in the fields of oncology, cardiovascular health, and infectious diseases.
With a robust operational presence across major regions in China and expanding internationally, WuZhong Pharma is renowned for its commitment to quality and research-driven approaches. The company offers a diverse portfolio of pharmaceutical products, including generic medications and proprietary formulations, distinguished by their efficacy and safety profiles.
Recognised for its contributions to healthcare, WuZhong Pharma has achieved notable milestones, positioning itself as a trusted name in the pharmaceutical sector. Its dedication to advancing medical science continues to drive its growth and reputation in the global market.
-19 vs industry average
JiangSu WuZhong Pharmaceutical Development Co., Ltd.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for JiangSu WuZhong Pharmaceutical Development Co., Ltd. yet.
JiangSu WuZhong Pharmaceutical Development Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures. Consequently, there are no recorded emissions totals, including Scope 1, Scope 2, or Scope 3 emissions.
Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards reducing carbon emissions or addressing climate change.
As the pharmaceutical industry increasingly prioritises sustainability, JiangSu WuZhong Pharmaceutical Development Co., Ltd. may need to consider developing a comprehensive climate strategy to align with global standards and expectations.
No climate goals have been disclosed for JiangSu WuZhong Pharmaceutical Development Co., Ltd. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more